Trials / Completed
CompletedNCT02402296
Host Modulatory Effects of β-glucan on Localized Aggressive Periodontitis
Efficacy of β-glucan in Treatment of Localized Aggressive Periodontitis: A Short Term Double-blinded, Placebo-controlled, Randomized Clinical Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- All
- Age
- 20 Years – 27 Years
- Healthy volunteers
- Not accepted
Summary
combining the non-surgical therapy with a well-tolerated substance that can stimulate protective immune responses like B-glucan, might effectively mount resolution pathways contributing to resolving of the chronic lesion observed in aggressive forms of periodontal disease.
Detailed description
Aim: To investigate the efficacy of β-glucan supplementation to non-surgical periodontal therapy in localized aggressive periodontitis (LAP) patients. Method: 30 subjects were randomly and equally assigned to receive scaling and root planing; either with placebo pills (Group I) or β-glucan (100 mg/once a day) (Group II), for 40 days. Subjects were clinically monitored on day 0 and day 91. Gingival samples were harvested from hopeless teeth sites to be investigated histologically and immunohistochemically using matrix metalloproteinase (MMP)-1 and 9 antibodies form each patient; at the same time intervals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | β-1,3/1,6-D-glucan | 15 patients (in group II) suffering from localized aggressive periodontitis followed a strict plaque control program (within two weeks); followed by a systemic course of β-1,3/1,6-D-glucan oral supplementation for 40 days. |
| OTHER | Placebo | 15 patients (in group I) suffering from localized aggressive periodontitis followed a strict plaque control program (within two weeks); followed by a systemic course of placebo capsules oral supplementation for 40 days. |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2014-06-01
- Completion
- 2014-08-01
- First posted
- 2015-03-30
- Last updated
- 2015-06-09
- Results posted
- 2015-06-09
Source: ClinicalTrials.gov record NCT02402296. Inclusion in this directory is not an endorsement.